• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Nebius Group N.V.

    5/2/25 4:02:53 PM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology
    Get the next $NBIS alert in real time by email
    S-8 1 tm2513807d1_s8.htm FORM S-8

     

    As filed with the Securities and Exchange Commission on May 2, 2025

     

    Registration No. 333-

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM S-8

     

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

    NEBIUS GROUP N.V.

    (Exact name of Registrant as specified in its charter)

     

    The Netherlands   Not Applicable
    (State or other jurisdiction of
    incorporation or organization)
      (I.R.S. Employer
    Identification Number)

     

    Schiphol Boulevard 165

    1118 BG, Schiphol, the Netherlands

    Tel: +31 20-206-6970

    (Address of Principal Executive Offices)

     

     

    Nebius Group N.V. Amended and Restated Equity Incentive Plan

    (Full Title of the Plan)

     

     

    ADC Tech, Inc.

    10 State Street

    Newburyport, MA 01950

    United States

    Tel: +1 832 998 2216

    (Name and Address of Agent for Service)

    (Telephone Number, Including Area Code, of Agent for Service)

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer x   Accelerated filer ¨
             
    Non-accelerated filer ¨   Smaller reporting company ¨
             
        Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ¨

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    This Registration Statement on Form S-8 (this “Registration Statement”) is being filed by Nebius Group N.V. (the “Registrant”) solely for the purpose of registering an additional 30,000,000 class A ordinary shares of the Registrant, nominal value €0.01 (the “Class A Shares”) to be offered to participants under the Nebius Group N.V. Amended and Restated Equity Incentive Plan (the “Plan”). The Plan was originally adopted at the annual general meeting of the Registrant’s shareholders on May 27, 2016 and was subsequently amended on June 27, 2019 and amended and restated at the annual general meeting on August 14, 2024.

     

    The Class A Shares registered hereby are in addition to and of the same class as those on the Registrant’s registration statement on Form S-8 filed with the Securities and Exchange Commission (the “Commission”) on August 25, 2016 (File No. 333-213317). In accordance with General Instruction E to Form S-8, the contents of such previously filed registration statement on Form S-8 are hereby incorporated herein by reference and the information required by Part II is omitted, except as supplemented by the information set forth below.

     

    PART II

     

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3. Incorporation of Documents by Reference.

     

    The following documents filed by the Registrant with the Commission are incorporated herein by reference:

     

    ·the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2024, filed with the Commission on April 30, 2025; and

     

    ·the Registrant’s description of its ordinary shares contained in Exhibit 2.1 of the Registrant’s Annual Report on Form 20-F (file no. 001-35173) filed with the Securities and Exchange Commission on April 30, 2025, and including any amendments and reports filed for the purpose of updating such description.

     

    All reports and other documents filed by the Registrant after the date hereof pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be part hereof from the date of filing of such reports and documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

     

    Item 8. Exhibits.

     

    The exhibits to this registration statement are listed in the below Exhibit Index and are incorporated by reference herein.

     

    Exhibit Index

     

    Exhibit       Incorporated by Reference   Filed
    Number   Exhibit Description   Form   Date   Number   Herewith
    4.1   Articles of Association of the Registrant, as currently in effect.   20-F   April 30, 2025   1.1    
    4.2   Nebius Group N.V. Amended and Restated Equity Incentive Plan   20-F   April 30, 2025   2.2    
    5.1   Opinion of DLA Piper Nederland N.V.               x
    23.1   Consent of Reanda Audit & Assurance B.V.               x
    23.2   Consent of Joint-Stock Company “Technologies of Trust – Audit”               x
    23.3   Consent of DLA Piper Nederland N.V (included in Exhibit 5.1).               x
    24.1   Power of Attorney (incorporated by reference to the signature page hereto).               x
    107   Filing Fee Table               x

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Schiphol, the Netherlands on May 2, 2025.

     

      NEBIUS GROUP N.V.
       
      By: /s/ Arkady Volozh
        Arkady Volozh
        Chief Executive Officer and Executive Director

     

    POWER OF ATTORNEY

     

    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Arkady Volozh and Ophir Nave, and each of them, with full power of substitution and full power to act without the other, his or her true and lawful attorneys-in-fact and agents to act for him or her in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file this registration statement, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the date indicated.

     

    Name   Title   Date
    /s/ Arkady Volozh   Chief Executive Officer and Executive Director   May 2, 2025
    Arkady Volozh   (Principal Executive Officer)    
             
    /s/ Ron Jacobs   Chief Financial Officer   May 2, 2025
    Ron Jacobs   (Principal Financial Officer and Principal Accounting Officer)    
             
    /s/ Ophir Nave   Chief Operating Officer and Executive Director   May 2, 2025
    Ophir Nave        
             
    /s/ John Boynton   Non-Executive Director   May 2, 2025
    John Boynton        
             
    /s/ Elena Bunina   Non-Executive Director   May 2, 2025
    Elena Bunina        
             
    /s/ Esther Dyson   Non-Executive Director   May 2, 2025
    Esther Dyson        
             
    /s/ Kira Radinsky   Non-Executive Director   May 2, 2025
    Kira Radinsky        
             
    /s/ Rogier Rijnja   Non-Executive Director   May 2, 2025
    Rogier Rijnja        
             
    /s/ Charles Ryan   Non-Executive Director   May 2, 2025
    Charles Ryan        

     

     

     

     

    SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES

     

    KNOW ALL PERSONS BY THESE PRESENTS, that the person whose signature appears below does hereby constitute and appoint Arkady Volozh and Ophir Nave, and each of them, as his true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitutes, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement on Form S-8 has been signed below by the undersigned, a duly authorized representative in the United States of Nebius Group N.V., on this 2nd day of May 2025.

     

    ADC Tech Inc.  
       
    By: /s/ Dmitry Romashev  
    Name: Dmitry Romashev  
    Title: President  

     

     

     

    Get the next $NBIS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NBIS

    DatePrice TargetRatingAnalyst
    1/15/2026$126.00Equal-Weight
    Morgan Stanley
    11/19/2025$175.00Mkt Outperform
    Citizens JMP
    9/15/2025Neutral
    Seaport Research Partners
    7/14/2025$68.00Buy
    Goldman
    6/5/2025$84.00Buy
    Arete
    5/6/2025$34.00Outperform
    Northland Capital
    2/25/2025$50.00Buy
    DA Davidson
    2/24/2025$51.00 → $60.00Buy
    BWS Financial
    More analyst ratings

    $NBIS
    SEC Filings

    View All

    SEC Form 144 filed by Nebius Group N.V.

    144 - Nebius Group N.V. (0001513845) (Subject)

    12/30/25 9:33:06 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Nebius Group N.V.

    SCHEDULE 13G/A - Nebius Group N.V. (0001513845) (Subject)

    11/14/25 12:37:21 PM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    SEC Form 6-K filed by Nebius Group N.V.

    6-K - Nebius Group N.V. (0001513845) (Filer)

    11/13/25 7:01:49 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $NBIS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Morgan Stanley initiated coverage on Nebius Group N.V. with a new price target

    Morgan Stanley initiated coverage of Nebius Group N.V. with a rating of Equal-Weight and set a new price target of $126.00

    1/15/26 8:38:40 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Citizens JMP initiated coverage on Nebius Group N.V. with a new price target

    Citizens JMP initiated coverage of Nebius Group N.V. with a rating of Mkt Outperform and set a new price target of $175.00

    11/19/25 8:57:24 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Seaport Research Partners initiated coverage on Nebius Group N.V.

    Seaport Research Partners initiated coverage of Nebius Group N.V. with a rating of Neutral

    9/15/25 8:09:01 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $NBIS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nebius Group N.V. Announces Date of Fourth Quarter and Full Year 2025 Results and Conference Call

    Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS) will release its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, before market open. Nebius Group will also hold a conference call to discuss its results at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time / 2:00 p.m. Central European Time) on the same day. The registration link to access the webcast and its replay will be available on Nebius Group's Investor Relations website at https://nebius.com/investor-hub. About Nebius Group Nebius Group (NASDAQ:NBIS) is a technology company building full-stack infrastructure for the global AI industry. Headquartered in Amsterdam and listed on Nas

    2/2/26 2:39:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Tradr Rolls Out Short Leveraged ETFs on APLD, IREN, LCID & NBIS

    Funds seek 200% inverse daily exposure on Applied Digital, IREN, Lucid and Nebius stock NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today launched four new short leveraged ETFs on single stocks. The Cboe-listed funds seek to deliver the inverse of twice (-200%) the daily performance of a specific underlying stock. The following ETFs are expected to open for trading today: Tradr 2X Short APLD Daily ETF (Cboe: APLZ) – tracks Applied Digital Corporation (NASDAQ:APLD)Tradr 2X Short IREN Daily ETF (Cboe: IREZ) – tracks IREN Limited (NASDAQ:IREN)Tradr 2X Short LCID Daily ETF (Cboe: LCIZ) – tracks Lucid Group

    1/22/26 6:46:00 AM ET
    $APLD
    $IREN
    $LCID
    Finance: Consumer Services
    Finance
    EDP Services
    Technology

    Nebius to Offer NVIDIA Vera Rubin NVL72 in US and Europe From H2 2026

    Nebius will be among the first NVIDIA Cloud Partners to bring the next-generation accelerated computing platform to market Nebius (NASDAQ:NBIS) will deploy the NVIDIA Rubin platform through Nebius AI Cloud and Nebius Token Factory, unlocking next-generation reasoning and agentic AI capabilities for customers starting H2 2026. Nebius, an NVIDIA Cloud Partner, will be among the first AI cloud providers to offer NVIDIA Vera Rubin NVL72. Nebius will integrate Vera Rubin NVL72 across its full-stack infrastructure at data centers in the US and Europe, enabling customers to build next-generation AI applications with regional availability and control. Launched at CES 2026, Vera Rubin NVL72

    1/6/26 5:54:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $NBIS
    Leadership Updates

    Live Leadership Updates

    View All

    Marc Boroditsky Joins Nebius as Chief Revenue Officer

    Nebius (NASDAQ:NBIS), a leading AI infrastructure company, today announced the appointment of Marc Boroditsky as Chief Revenue Officer as the company continues to build out its global sales team. A seasoned senior tech executive, Marc has a strong global go-to-market track record of driving high growth – in five years at Twilio he grew paying customers six times, and revenue more than 10 times to $4 billion. Previously he founded several successful companies, and served as a senior leader at Oracle and most recently Cloudflare. Arkady Volozh, founder and CEO of Nebius, welcomed Marc to the company: "We are building a global company and planning to grow many times in the coming years.

    5/28/25 7:30:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $NBIS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Nebius Group N.V.

    SC 13G/A - Nebius Group N.V. (0001513845) (Subject)

    11/12/24 10:32:14 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $NBIS
    Financials

    Live finance-specific insights

    View All

    Nebius Group N.V. Announces Date of Fourth Quarter and Full Year 2025 Results and Conference Call

    Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS) will release its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, before market open. Nebius Group will also hold a conference call to discuss its results at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time / 2:00 p.m. Central European Time) on the same day. The registration link to access the webcast and its replay will be available on Nebius Group's Investor Relations website at https://nebius.com/investor-hub. About Nebius Group Nebius Group (NASDAQ:NBIS) is a technology company building full-stack infrastructure for the global AI industry. Headquartered in Amsterdam and listed on Nas

    2/2/26 2:39:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Nebius Group N.V. announces date of third quarter 2025 results and conference call

    Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS) will release its third quarter 2025 financial results on Tuesday, November 11, 2025, before market open. Nebius Group will also hold a conference call to discuss its results at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time / 2:00 p.m. Central European Time) on the same day. The registration link to access the webcast and its replay will be available on Nebius Group's Investor Relations website at https://nebius.com/investor-hub. About Nebius Group Nebius Group (NASDAQ:NBIS) is a technology company building full-stack infrastructure for the global AI industry. Headquartered in Amsterdam and listed on Nasdaq, Nebius Grou

    10/22/25 8:23:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform

    MarketNewsUpdates News Commentary NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The global Diagnostic Biomarker market is experiencing unprecedented growth and is projected to continue to see substantial growth in years to come. A recent report from the (NIH) National Library of Medicine discussed the AI-Assisted Biomarker, said that: "Recently, advancements in healthcare digitization and personalized treatments have led to groundbreaking developments. Utilization of AI and ML has the potential to enhance comprehension of disease onset and progression, potentially uncovering new disease subtypes, unveiling novel drug targets, advancing the field of precision medicine, propelling efforts towards d

    9/11/25 8:45:00 AM ET
    $APLD
    $NBIS
    $NVDA
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology